Literature DB >> 17601989

Economic consequences of the obese.

C Ford Runge1.   

Abstract

The private and social costs of obesity have many causes, and their consequences can be grimly predicted with only rough accuracy. Among the most devastating is the increased incidence of diabetes, of which 60% can be directly attributed to weight gain. There are now about one billion people worldwide who are overweight or obese, compared with 850 million who are chronically underweight. It is estimated that the number of people worldwide with diabetes will increase from 175 million in 2000 to 353 million in 2030, with India and China together accounting for 24% of the total in 2050. Obesity and its economic costs are borne on three levels. At an individual level, obesity imposes costs by limiting personal opportunity in many ways, only some of which can be quantified. In the workplace (assuming the obese are employed, which they may not be, due in part to their condition), costs are borne by employers due to lost productivity, absences, underperformance, and higher insurance premia, which in the aggregate are quite large. Finally, obesity affects expenditures by local, state, and national governments, where programs compensate for or cover some of the private and workforce costs of illness and unemployment.

Entities:  

Mesh:

Year:  2007        PMID: 17601989     DOI: 10.2337/db07-0633

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  23 in total

1.  The effect of training on performance and health in middle age.

Authors:  D Leyk; A Sievert
Journal:  Herz       Date:  2012-08       Impact factor: 1.443

Review 2.  The Impact of Obesity in the Workplace: a Review of Contributing Factors, Consequences and Potential Solutions.

Authors:  Nipun Shrestha; Zeljko Pedisic; Sarah Neil-Sztramko; Katriina T Kukkonen-Harjula; Veerle Hermans
Journal:  Curr Obes Rep       Date:  2016-09

3.  Rapid upregulation of sodium-glucose transporter SGLT1 in response to intestinal sweet taste stimulation.

Authors:  Adam T Stearns; Anita Balakrishnan; David B Rhoads; Ali Tavakkolizadeh
Journal:  Ann Surg       Date:  2010-05       Impact factor: 12.969

4.  Excess direct medical costs of severe obesity by socioeconomic status in German adults.

Authors:  Thomas von Lengerke; Jürgen John; Andreas Mielck
Journal:  Psychosoc Med       Date:  2010-04-20

5.  Socioeconomic status and prevalence of obesity and diabetes in a Mexican American community, Cameron County, Texas, 2004-2007.

Authors:  Susan P Fisher-Hoch; Anne R Rentfro; Jennifer J Salinas; Adriana Pérez; H Shelton Brown; Belinda M Reininger; Blanca I Restrepo; J Gaines Wilson; M Monir Hossain; Mohammad H Rahbar; Craig M Hanis; Joseph B McCormick
Journal:  Prev Chronic Dis       Date:  2010-04-15       Impact factor: 2.830

Review 6.  Damaging effects of a high-fat diet to the brain and cognition: a review of proposed mechanisms.

Authors:  Linnea R Freeman; Vivian Haley-Zitlin; Dorothea S Rosenberger; Ann-Charlotte Granholm
Journal:  Nutr Neurosci       Date:  2013-11-26       Impact factor: 4.994

7.  Self-reported vs measured body mass indices in migraineurs.

Authors:  Michael J Katsnelson; B Lee Peterlin; Andrea L Rosso; Guillermo M Alexander; Kirsten L Erwin
Journal:  Headache       Date:  2009-05       Impact factor: 5.887

Review 8.  Metabolic support of the obese intensive care unit patient: a current perspective.

Authors:  Ava M Port; Caroline Apovian
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-03       Impact factor: 4.294

9.  Physical fitness, weight, smoking, and exercise patterns in young adults.

Authors:  Dieter Leyk; Thomas Rüther; Alexander Witzki; Alexander Sievert; Anne Moedl; Maria Blettner; Dieter Hackfort; Herbert Löllgen
Journal:  Dtsch Arztebl Int       Date:  2012-11-02       Impact factor: 5.594

10.  Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity.

Authors:  Ivy K M Law; Aimin Xu; Karen S L Lam; Thorsten Berger; Tak W Mak; Paul M Vanhoutte; Jacky T C Liu; Gary Sweeney; Mingyan Zhou; Bo Yang; Yu Wang
Journal:  Diabetes       Date:  2010-01-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.